Weaver C. Barksdale & Associates’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$51K Buy
2,697
+995
+58% +$22.1K 0.05% 90
2017
Q3
$50K Buy
1,702
+126
+8% +$3.72K 0.06% 87
2017
Q2
$51K Buy
1,576
+129
+9% +$4.23K 0.06% 85
2017
Q1
$50K Sell
1,447
-139
-9% -$4.96K 0.06% 85
2016
Q4
$56K Buy
1,586
+175
+12% +$5.91K 0.09% 85
2016
Q3
$49K Buy
1,411
+59
+4% +$2.06K 0.08% 90
2016
Q2
$51K Buy
1,352
+212
+19% +$7.97K 0.09% 78
2016
Q1
$46K Sell
1,140
-134
-11% -$4.99K 0.03% 109
2015
Q4
$46K Sell
1,274
-98
-7% -$3.54K 0.04% 110
2015
Q3
$44K Sell
1,372
-71
-5% -$2.42K 0.04% 111
2015
Q2
$49K Buy
1,443
+56
+4% +$1.89K 0.04% 110
2015
Q1
$47K Sell
1,387
-22,865
-94% -$797K 0.04% 111
2014
Q4
$851K Sell
24,252
-43
-0.2% -$1.45K 0.68% 41
2014
Q3
$795K Buy
24,295
+3,052
+14% +$104K 0.66% 46
2014
Q2
$722K Buy
21,243
+22
+0.1% +$754 0.58% 67
2014
Q1
$743K Buy
21,221
+78
+0.4% +$2.75K 0.62% 54
2013
Q4
$773K Sell
21,143
-52
-0.2% -$1.91K 0.65% 41
2013
Q3
$733K Sell
21,195
-20
-0.1% -$700 0.67% 41
2013
Q2
$718K Buy
+21,215
New +$704K 0.71% 34

Other funds holding ACH

Weaver C. Barksdale & Associates's ACH Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Accendra Health (ACH) stake by 58% in Q4 2017, buying an estimated $22.1K and bringing the position to 2,697 shares worth $51K. The position accounts for 0.05% of the portfolio, ranked #90.

Weaver C. Barksdale & Associates first reported a position in ACH in Q2 2013 and has held it in 19 quarters since. The position peaked at $851K in Q4 2014. 230 funds tracked by Wall St. Rank hold ACH as of Q4 2017.

  • Weaver C. Barksdale & Associates held 2,697 shares of Accendra Health worth $51K as of Q4 2017.
  • Weaver C. Barksdale & Associates bought 995 Accendra Health shares in Q4 2017, an estimated $22.1K.
  • Accendra Health made up 0.05% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #90 holding.
  • Weaver C. Barksdale & Associates first reported a position in Accendra Health in Q2 2013 and has held it in 19 quarters since.
  • Weaver C. Barksdale & Associates's Accendra Health position peaked at $851K in Q4 2014.
  • 230 funds tracked by Wall St. Rank held Accendra Health as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.